Featured Research

from universities, journals, and other organizations

Study Aims To Cut Deaths From Severe Infection In Hospital Wards

Date:
June 8, 2006
Source:
University of Edinburgh
Summary:
Researchers at the University of Edinburgh are aiming to reduce the risks posed by a life-threatening condition which affects four in ten of Scottish intensive care patients. The project will measure the extent of severe sepsis -- life-threatening bacterial infection -- in Scottish hospitals.

Researchers at the University of Edinburgh are aiming to reduce the risks posed by a life-threatening condition which affects four in ten of Scottish intensive care patients. The project will measure the extent of severe sepsis -- life-threatening bacterial infection -- in Scottish hospitals.

Severe sepsis, where there is infection plus major organ failure, is a significant health problem, causing death and ill-health and consuming substantial NHS resources. These septic infections can be acquired outside hospital or can be the result of hospital diseases like MRSA. Patients with chronic diseases such as coronary heart disease, cancer, stroke or diabetes have an increased risk of severe sepsis and a poorer chance of successfully overcoming the infection. About half of intensive care unit patients with sepsis in the UK die from the infection,

Researcher Dr Pam Warner said: "At the moment, there is no reliable method for identifying and tracking sepsis rates or outcomes in UK hospitals, as for example, we are able to do with people who have had heart attacks."

Intensive care physician Dr Simon Mackenzie of Edinburgh Royal Infirmary, one of the co-investigators, emphasised: "Reliable data is needed to be able to plan resources such as extra intensive care unit beds and 'outreach' specialised support for care of hospital patients not admitted to intensive care. It would also allow us to assess the impact of campaigns to reduce rates of severe sepsis or to improve outcome -- ultimately to cut the death rates."

The 18-month research project is funded by the Chief Scientist Office.


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Cite This Page:

University of Edinburgh. "Study Aims To Cut Deaths From Severe Infection In Hospital Wards." ScienceDaily. ScienceDaily, 8 June 2006. <www.sciencedaily.com/releases/2006/06/060608090953.htm>.
University of Edinburgh. (2006, June 8). Study Aims To Cut Deaths From Severe Infection In Hospital Wards. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2006/06/060608090953.htm
University of Edinburgh. "Study Aims To Cut Deaths From Severe Infection In Hospital Wards." ScienceDaily. www.sciencedaily.com/releases/2006/06/060608090953.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins